The Modern Primary Care Tool: Why Your GP Recommends GLP-1s

In recent years, General Practitioners (GPs) have increasingly integrated glucagon-like peptide-1 receptor agonists (GLP-1 RAs) into routine care. GLP-1 usage in primary care is on the rise because these medications offer a powerful combination of blood sugar control, weight management and cardiovascular protection. Below, we'll explore what GLP-1s are, why your GP might suggest them, and how they fit into a broader care plan—without glossing over what you need to know.

What Are GLP-1 Receptor Agonists?

Glucagon-like peptide-1 (GLP-1) is a naturally occurring gut hormone (an incretin) that helps regulate glucose and appetite. GLP-1 receptor agonists are synthetic versions that mimic this hormone to:

• Boost glucose-dependent insulin secretion
• Suppress inappropriate glucagon release
• Slow gastric emptying, increasing satiety
• Reduce appetite and caloric intake

Commonly prescribed GLP-1 RAs in primary care include:

• Liraglutide
• Semaglutide
• Dulaglutide
• Exenatide

These drugs are endorsed by leading bodies such as the American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD) and the National Institute for Health and Care Excellence (NICE) for their benefits in type 2 diabetes and obesity management.

Why Your GP Recommends GLP-1s

1. Improved Glycemic Control

• Average HbA1c reductions of 1.0%–1.5% when added to metformin or other oral agents
• Low risk of hypoglycemia because insulin release is glucose-dependent

2. Weight Management

• Sustained weight loss of 5–15% of body weight in many patients
• Useful for people with type 2 diabetes who also struggle with overweight or obesity

3. Cardiovascular Benefits

• Reduction in major adverse cardiovascular events (MACE) by 10–20% in high-risk patients
• Proven benefits in patients with established heart disease

4. Potential Renal Protection

• Slowing of diabetic kidney disease progression has been observed
• Particularly beneficial for patients with early signs of nephropathy

5. Simplified Regimens

• Once-weekly formulations (e.g., dulaglutide, semaglutide) improve adherence
• Clear titration schedules make it easier to manage side effects

Who Is a Good Candidate?

GLP-1 usage in primary care focuses on patients who:

• Have type 2 diabetes not controlled by metformin and lifestyle changes
• Struggle with overweight (BMI ≥27 kg/m²) or obesity (BMI ≥30 kg/m²) with comorbidities
• Have established cardiovascular disease or high CV risk
• Are unable to tolerate or have contraindications to other antihyperglycemic drugs

Initial Evaluation

Before starting a GLP-1 RA, your GP will typically:

• Review your medical history (especially GI disorders, personal/family history of thyroid carcinoma or multiple endocrine neoplasia type 2)
• Check kidney and liver function
• Confirm baseline HbA1c, weight and BMI
• Discuss cost, insurance coverage and patient assistance programs

Practical Aspects of GLP-1 Usage in Primary Care

Dosing and Administration

• Daily injections (e.g., liraglutide) or weekly injections (e.g., dulaglutide, semaglutide)
• Start with a low dose, then titrate every 1–4 weeks to minimize side effects
• Administer at any time of day, with or without food, depending on the formulation

Monitoring

• HbA1c every 3–6 months
• Weight and BMI at each visit
• Renal function (eGFR) annually or as clinically indicated
• Gastrointestinal tolerance—ask about nausea, vomiting, diarrhea

Managing Side Effects

GI side effects are common, especially early on:

• Nausea, vomiting, diarrhea
• Abdominal pain
• Injection site reactions

Strategies to improve tolerance:

• Slow titration: Increase the dose in small increments
• Dietary adjustments: Eat smaller, more frequent meals; avoid high-fat foods
• Stay hydrated and consider separate sips of water between meals

Safety and Contraindications

While generally well tolerated, GLP-1 RAs are not suitable for everyone. Contraindications include:

• Personal or family history of medullary thyroid carcinoma or MEN 2
• History of pancreatitis (use with caution and close monitoring)
• Pregnancy and breastfeeding (insufficient safety data)
• Severe gastrointestinal disease (e.g., gastroparesis)

Your GP will weigh these factors and choose the most appropriate therapy.

Integrating GLP-1s Into Holistic Care

GLP-1 usage in primary care is part of a broader strategy that includes:

• Lifestyle modification: Nutrition counseling, physical activity, sleep hygiene
• Cardiovascular risk management: Blood pressure control, lipid-lowering therapy
• Behavioral support: Referrals to dietitians, diabetes educators, mental health professionals
• Medication optimization: Adjusting metformin, SGLT2 inhibitors, insulin or other agents as needed

By combining GLP-1 RAs with these elements, GPs can tailor care to each patient's unique needs.

Access and Cost Considerations

• Insurance coverage varies; many plans cover at least one GLP-1 RA
• Patient assistance programs from manufacturers can reduce out-of-pocket costs
• Discuss with your GP or clinic pharmacist for options that fit your budget

Next Steps: Talk to Your GP (and Try a Symptom Check)

If you think GLP-1 therapy might be right for you, schedule an appointment with your GP. They can:

• Review your medical history and current medications
• Order any baseline labs needed
• Discuss risks, benefits and insurance coverage

Before your appointment, you can get a head start by checking your symptoms with Ubie's free Medically Approved LLM Symptom Checker Chat Bot, which can help you organize your concerns and prepare thoughtful questions to discuss with your doctor during your visit.

Important: If you experience any severe symptoms—such as chest pain, sudden shortness of breath, severe abdominal pain or signs of an allergic reaction—seek emergency care or call your GP immediately. Always speak to a doctor about anything that could be life-threatening or serious.

---

GLP-1 receptor agonists represent a transformative tool in primary care, offering a well-rounded approach to diabetes, weight management and cardiovascular risk. By understanding how they work, who benefits most and how to manage potential side effects, you and your GP can make informed decisions that support your long-term health.